Biomerica (BMRA) Other Non Operating Income (2010 - 2026)
Biomerica (BMRA) reported Other Non Operating Income of -$6000.0 for Q1 2026, down 113.95% on a YoY basis from $43000.0 in Q1 2025, and up 97.21% sequentially from -$215000.0 in Q2 2025.
Biomerica (BMRA) Other Non Operating Income (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 6 years of Other Non Operating Income data on file, last reported at -$6000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 113.95% year-over-year to -$6000.0; the trailing twelve-month figure through Feb 2026 stood at -$173014.0 (down 407.9% YoY), and the FY2025 full-year result was -$75000.0, up 56.4% from the prior year.
- Other Non Operating Income improved to -$6000.0 in Q1 2026, from -$215000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $43000.0 in Q1 2025 to a low of -$215000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -6,000.00 |
| May 31, 2025 | -215,000.00 |
| Feb 28, 2025 | 43,000.00 |
| May 31, 2013 | 4,986.00 |
| Feb 28, 2013 | 7,079.00 |
| Nov 30, 2012 | 1,127.00 |
| Aug 31, 2012 | 808.00 |
| May 31, 2012 | 27,265.00 |
| Feb 29, 2012 | 72,526.00 |
| Nov 30, 2011 | 1,006.00 |
| Aug 31, 2011 | 891.00 |
| May 31, 2011 | 113,523.00 |
| Feb 28, 2011 | 388.00 |
| Nov 30, 2010 | 177,752.00 |